New interim CFO in Biotie

BIOTIE THERAPIES CORP.         STOCK EXCHANGE RELEASE   1 September 2011 at 1
p.m.
 
New interim CFO in Biotie
 
Biotie's interim Chief Financial Officer Ulla Sjöblom will be leaving the
company to pursue other interests. Zack McNealy, Vice President, Finance of the
group's US subsidiary will assume the role of acting Chief Financial Officer
starting September 1, 2011. The Company expects to conclude the ongoing CFO
search process by the end of this year.
 
Zack McNealy has been Vice President, Finance of Biotie Therapies, Inc.
(formerly Synosia Therapeutics) since 2007. Before this, he served as a Plant
Controller, Finance Manager, and Financial Analyst with Johnson & Johnson from
1997-2006.
 
Turku, 1 September 2011
 
Biotie Therapies Corp.
 
Timo Veromaa
President and CEO
 
For further information, please contact:
 
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail: virve.nurmi@biotie.com
 
DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com
 
This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
 
Source: Biotie Therapies Oyj via Thomson Reuters ONE
 
[HUG#1543410]